| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.2 |
2e-09 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
5e-09 |
| mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
1e-08 |
| mRNA |
indisulam |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
3e-08 |
| mRNA |
Nutlin-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
2e-07 |
| mRNA |
CD-437 |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
4e-07 |
| mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
6e-07 |
| mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
1e-06 |
| mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.17 |
2e-06 |
| mRNA |
KIN001-266 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
3e-06 |